Osteopontin in diabetic nephropathy: Signpost or road

Kidney International

Volumn 77, Issue 7, 2010, Pages 565-566

  Heuer, Josef G ^a   Breyer, Matthew D ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ANGIOTENSIN RECEPTOR ANTAGONIST; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; NEUTRALIZING ANTIBODY; OSTEOPONTIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; ROSIGLITAZONE; STRESS ACTIVATED PROTEIN KINASE; THROMBIN; TRANSFORMING GROWTH FACTOR BETA; UROKINASE;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; BINDING AFFINITY; CELL ADHESION; CELL INFILTRATION; CELL MIGRATION; CELL MOTILITY; CYTOKINE RELEASE; DIABETIC NEPHROPATHY; DIALYSIS; DISEASE COURSE; DRUG EFFECT; DRUG TARGETING; HYPERGLYCEMIA; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY FIBROSIS; KNOCKOUT MOUSE; MACROPHAGE; MESANGIUM CELL; MICROALBUMINURIA; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MODIFICATION; RENAL PROTECTION; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES; UPREGULATION;

EID: 77949504129     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2009.515     Document Type: Note

References (9)

1. Dronavalli S, Duka I, Bakris GL.The pathogenesis of diabetic nephropathy. Nat Clin Pract Endocrinol Metab 2008; 4: 444-452.
2. Nicholas SB, Liu J, Kim Jet al. Critical role for osteopontin in diabetic nephropathy. Kidney Int 2010;77: 588-600.
3. Scatena M, Liaw L, Giachelli CM. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler Thromb Vasc Biol 2007; 27: 2302-2309.
4. Nau GJ, Liaw L, Chupp GL et al. Attenuated host resistance against Mycobacterium bovis BCG infection in mice lacking osteopontin. Infect Immun 1999; 67: 4223-4230.
5. Lorenzen J, Shah R, Biser A et al. The role of osteopontin in the development of albuminuria. J Am Soc Nephrol 2008; 19: 884-890.
6. Ophascharoensuk V, Giachelli CM, Gordon K et al. Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int 1999;56: 571-580.
7. Wolak T, Kim H, Ren Yet al. Osteopontin modulates angiotensin II-induced inflammation, oxidative stress, and fibrosis of the kidney. Kidney Int 2009; 76: 32-43.
8. Panzer U , Thaiss F , Zahner G et al. Monocyte chemoattractant protein-1 and osteopontin differentially regulate monocytes recruitment in experimental glomerulonephritis. Kidney Int 2001; 59:1762-1769.
9. Oyama Y , Akuzawa N , Nagai R , Kurabayashi M. PPARy ligand inhibits osteopontin gene expression through interference with binding of nuclear factors to A/T-rich sequence in THP-1 cells. Circ Res 2002; 90: 348-355.